Iconovo AB — Investor Relations & Filings

Iconovo is a company that develops inhaled medicinal products in collaboration with pharmaceutical partners. It specializes in creating complete inhalation solutions, which include both patented dry powder inhalers (DPIs) and the corresponding drug formulations. The company's proprietary inhaler platforms, such as the multi-dose ICOres and the capsule-based ICOcap, are designed for treating respiratory diseases like asthma and Chronic Obstructive Pulmonary Disease (COPD). Iconovo offers an integrated development service, providing expertise from concept to commercial production, and licenses its technology to international pharmaceutical companies to bring new therapies to patients.